Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Sesti, Giorgio ^a   Sciacqua, Angela ^a   Fiorentino, Teresa Vanessa ^a   Perticone, Maria ^a   Succurro, Elena ^a   Perticone, Francesco ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; SOMATOMEDIN C;

ADULT; APRI INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BARD SCORE; CARDIOMETABOLIC RISK; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FATTY LIVER; FATTY LIVER INDEX; FEMALE; FIB 4 INDEX; FRAMINGHAM RISK SCORE; HEART LEFT VENTRICLE ENDDIASTOLIC DIAMETER; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HUMAN; INSULIN RESISTANCE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NAFLD FIBROSIS SCORE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SMOKING; WAIST CIRCUMFERENCE; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; GLUCOSE TOLERANCE TEST; HEART; HYPERTROPHY, LEFT VENTRICULAR; LIVER CIRRHOSIS; MIDDLE AGED; MORTALITY; NONALCOHOLIC FATTY LIVER; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HEART; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS;

EID: 84905827344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104941     Document Type: Article

References (41)

1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-95. (Pubitemid 39657013)
2. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, et al. (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42: 44-52. (Pubitemid 40911310)
3. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
4. Petta S, Muratore C, Craxi A (2009) Nonalcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis 41: 615-25.
5. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, et al (2002) Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123: 134-140. (Pubitemid 34747534)
6. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, et al. (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121. (Pubitemid 41002048)
7. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, et al. (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44: 865-873. (Pubitemid 46489550)
8. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, et al. (2009) Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 7: 234-238.
9. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850. (Pubitemid 33641605)
10. Stefan N, Kantartzis K, Haring HU (2008) Causes and metabolic consequences of fatty liver. Endocr Rev 29: 939-960.
11. Yki-Järvinen H (2010) Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis 28: 203-209.
12. Arturi F, Succurro E, Procopio C, Pedace E, Mannino GC, et al. (2011) Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-1. J Clin Endocrinol Metab 96: E1640-E1644.
13. Hribal ML, Procopio T, Petta S, Sciacqua A, Grimaudo S, et al. (2013) Insulin-Like Growth Factor-1, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab 98: E304-E308.
14. Sciacqua A, Perticone M, Miceli S, Laino I, Tassone EJ, et al. (2011) Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients. Nutr Metab Cardiovasc Dis 21: 485-491.
15. Sesti G, Fiorentino TV, Hribal ML, Sciacqua A, Perticone F (2013) Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers. Nutr Metab Cardiovasc Dis 23: 1182-7.
16. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363: 1341-1350.
17. Stepanova M, Younossi ZM (2012) Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol 10: 646-50.
18. Myers RP, Fong A, Shaheen AA (2008) Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int 28: 705-12. (Pubitemid 351541104)
19. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-26. (Pubitemid 36919874)
20. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, et al. (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45: 846-854. (Pubitemid 46631552)
21. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, et al. (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43: 1317-1325. (Pubitemid 43980111)
22. Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA (2008) Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57: 1441-1447.
23. Demir M, Lang S, Schlattjan M, Drebber U, Wedemeyer I, et al. (2013) NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD. PLoS One 8: e58360.
24. Treeprasertsuk S, Björnsson E, Enders F, Suwanwalaikorn S, Lindor KD (2013) NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. World J Gastroenterol 19: 1219-29.
25. Kim D, Kim WR, Kim HJ, Therneau TM (2013) Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 57: 1357-65.
26. Succurro E, Arturi F, Grembiale A, Iorio F, Fiorentino TV, et al. (2011) One-hour post-load plasma glucose levels are associated with elevated liver enzymes. Nutr Metab Cardiovasc Dis 21: 713-718.
27. Succurro E, Marini MA, Arturi F, Grembiale A, Lugarà M, et al. (2009) Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207: 245-249.
28. Sciacqua A, Miceli S, Carullo G, Greco L, Succurro E, et al. (2011) One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 34: 1406-1411.
29. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, et al. (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34: 2159-2219.
30. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458. (Pubitemid 16119719)
31. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, et al. (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6: 33.
32. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167.
33. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
34. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 97: 1837-1847. (Pubitemid 28213628)
35. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
36. Sesti G, Fiorentino TV, Arturi F, Perticone M, Sciacqua A, et al. (2014) Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease. PLoS One 9(2): e88569.
37. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-6. (Pubitemid 20176696)
38. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, et al. (2000) Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 35: 580-6. (Pubitemid 30108152)
39. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, et al. (1999) Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340: 14-22. (Pubitemid 29024679)
40. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, et al. (2006) Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 29: 1325-30. (Pubitemid 44125930)
41. Goland S, Shimoni S, Zornitzki T, Knobler H, Azoulai O, et al. (2006) Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 40: 949-955. (Pubitemid 44690772)